MedPath

Effectiveness of Point-of-care Lung Ultrasound for the Management of Childhood Lower Respiratory Infections

Not Applicable
Not yet recruiting
Conditions
LRTI
Bronchiolitis
Pneumonia
Lower Respiratory Infection
Interventions
Diagnostic Test: Point-of-care lung ultrasound
Diagnostic Test: Chest X-ray (digital images)
Registration Number
NCT05921526
Lead Sponsor
Nagasaki University
Brief Summary

The goal of this clinical trial is to evaluate the effectiveness of point-of-care lung ultrasound versus chest X-ray for the management of childhood lower respiratory infections in a low-resource setting.

The main question it aims to answer is:

Is point-of-care lung ultrasound as effective as chest X-ray for the management of childhood LRIs in a low-resource setting?

Participants will be assigned to either a point-of-care lung ultrasound group (intervention) or a chest X-ray group (control), to compare the effect on overall case management and various clinical outcomes (time to symptom resolution, rate of antibiotic use, length of stay, treatment costs).

Detailed Description

Background:

Lower respiratory infections (LRIs) are the leading causes of mortality in children of low-middle income countries (LMICs) including Nepal; pneumonia being the major killer in under-5 population. Often, the cause of mortality is the delay in diagnosis and treatment, particularly when clinical assessments do not hint toward a diagnosis. In resource-limited settings, routine availability of chest X-ray (CXR) service is a challenge, it can be hazardous to children due to exposure to ionizing radiation. The Point-Of-Care Lung UltraSound (POCLUS) could be an alternative solution for the diagnosis and management of LRIs. Studies have already shown that lung ultrasound has a higher sensitivity and specificity than CXR in diagnosing childhood LRIs, however, none of the studies have yet evaluated its role in overall case management.

Methods:

Prospective, single-center, pragmatic, open-label, randomized, controlled, non-inferiority clinical trial, which will be conducted in the outpatient and emergency departments of a pediatric hospital in Nepal. A total of 616 children with clinical suspicion of LRI and requiring chest imaging will be randomized at 1:1 allocation to the intervention (POCLUS) and control (CXR) arms. Pediatricians will be trained to perform lung ultrasonography in children.

Outcomes:

Primary outcome is the proportion of 'correctly (effectively) managed' cases. Secondary outcomes include the proportion of cases with 'change in diagnosis and management plan due to intervention', time to symptom resolution, rate of antibiotic use, length of stay, and in-hospital costs, compared between intervention and control groups.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
616
Inclusion Criteria
  • Children with a suspected lower respiratory infection (LRI) brought to the outpatient or emergency department,
  • Requiring chest image for evaluation at baseline.
Exclusion Criteria
  • Children already hospitalized, received antibiotics, or had chest imaging at the hospital;
  • Follow-up (treated within the past 4 weeks) or referred cases;
  • Critical patients requiring emergency life-saving support including oxygen;
  • Children with one or more danger signs (lethargy or loss of consciousness, convulsion, unable to eat or vomiting everything, cyanosis, excess irritability)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionPoint-of-care lung ultrasoundPoint-of-care lung ultrasound
ControlChest X-ray (digital images)Chest X-ray
Primary Outcome Measures
NameTimeMethod
Correct management plan at the baseline on the basis of clinical assessment and chest image findingsFrom the date of randomization until the final disposition of patient (i.e. discharge, refer), assessed up to 3 weeks. In case of non-hospitalized participants, outcomes evaluated during 2nd follow up (day 7-10 of enrollment), assessed up to 2 weeks.

Proportion of participants who are prescribed a correct management plan at the baseline on the basis of clinical assessment and chest image findings, either point-of-care lung ultrasound or chest X-ray

Secondary Outcome Measures
NameTimeMethod
Time to symptom/sign resolutionFrom the date of randomization until disposition (i.e. discharge, referral) or symptom resolution criteria is met, whichever is earlier, assessed up to 3 weeks.

In hospitalized cases only

In-hospital treatment costsFrom the date of randomization until disposition (i.e. discharge, referral), assessed up to 3 weeks.

In hospitalized cases only

Length of stay at hospitalFrom the date of randomization until disposition (i.e. discharge, referral), assessed up to 3 weeks.

In hospitalized cases only

Change in diagnosis and management planFrom the date of randomization until Day3-5 of enrollment, assessed up to 1 week.

* Diagnosis and Management Plan 1: Enrolling physician will fill a case report form with initial diagnosis and management plan (plan 1) based on the clinical assessment and LUS/CXR findings at baseline.

* Decision regarding actual diagnosis and management plan (1a) is on treating physician's discretion.

* Diagnosis and Management Plan 2: Enrolling physician will fill a second case report form (exactly same to the first one) on Day3-5 of enrollment with the diagnosis and management plan based on clinical assessment, chest image(s), and lab investigations.

This outcome is measured in hospitalized cases only.

Rate of antibiotic useFrom the date of randomization until disposition (i.e. discharge, referral), assessed up to 3 weeks.

In hospitalized cases only

Trial Locations

Locations (1)

Siddhi Memorial Hospital

🇳🇵

Bhaktapur, Bagmati, Nepal

© Copyright 2025. All Rights Reserved by MedPath